Latest Insulin therapy Stories
Data and analysis announced today in a poster presentation at the Academy of Managed Care Pharmacy's 27th Annual Meeting and Expo BRIDGEWATER, New Jersey, April 9, 2015 /PRNewswire/ --
According to the new report from BCC Research, the global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014.
Glucose Clamp Study is Expected to Complement Oramed's Planned Phase IIb Study JERUSALEM, April 1, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
Hepatic targeted insulin technology designed to make approved insulin therapies safer and more effective Cleveland, OH (PRWEB) March 31, 2015 Diasome
DALLAS, February 20, 2015 /PRNewswire/ -- Global and Chinese Human Insulin Industry, 2009-2019 Market Research Report and Human Insulin Market by Product Type (Human Insulin
- Patients transitioned easily from multiple-daily insulin injections to PaQ®, which safely and effectively managed blood glucose - HORW, Switzerland, Feb.
--Total Funds Raised to Date Exceed $33 Million-- BRISBANE, Calif., Feb. 18, 2015 /PRNewswire/ -- Dance Biopharm Inc.
Nearly 30 million people in the US struggle with some type of diabetes, but a newly-developed “smart” form of insulin could make treating the condition easier by self-monitoring blood sugar levels and activating only when needed.
BRISBANE, Calif., Feb. 11, 2015 /PRNewswire/ -- Dance Biopharm Inc.
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...